BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy
- PMID: 23134110
- DOI: 10.1111/cen.12096
BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy
Abstract
Context: Patients with primary adrenal insufficiency (PAI) and patients with congenital adrenal hyperplasia (CAH) receive weight-adapted standard glucocorticoid replacement therapy. Clinically, some patients appear more sensitive to therapeutic administration of glucocorticoids than others. Glucocorticoid sensitivity is at least partially genetically determined by polymorphisms of the glucocorticoid receptor (GR) and might influence bone mineral density (BMD).
Objectives: To determine if bone turnover markers and BMD are associated with the GR gene polymorphism BclI in patients with PAI and CAH.
Design and patients: A prospective, cross-sectional study including 74 PAI and 38 CAH patients. BMD was evaluated by DXA. Serum levels of bone turnover markers, minerals, vitamins and hormones, and urinary crosslinks were measured.
Results: Patients carrying the homozygous BclI polymorphism (GG) had significantly higher serum β-CrossLaps (0.37 ± 0.34 μg/l; P < 0.05) and urinary collagen crosslinks (NTX, 68.1 ± 32.4 nmol/g; P < 0.005) despite receiving the lowest average daily hydrocortisone dose of 9.9 ± 3.7 mg/m(2) (P < 0.05). The GG genotype occurred significantly more frequently in patients with increased NTX (OR=6.7, 95% CI = 1.78-25.38) than in patients with normal NTX. However, BMD was not significantly different between different allelic variants. No significant differences in associations of the genotypes with outcomes (or in clinical characteristics) were found between the sexes.
Conclusions: Although the sample sizes were relatively small and the results should be interpreted with caution, this study suggests that the homozygous (GG) genotype may be associated with higher bone resorption in adult PAI and CAH patients. GG-carriers needed a lower hydrocortisone dose on average supporting the concept that this GR variant is associated with increased cortisol sensitivity.
© 2012 John Wiley & Sons Ltd.
Similar articles
-
Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.J Clin Endocrinol Metab. 2012 Jan;97(1):85-92. doi: 10.1210/jc.2011-2036. Epub 2011 Oct 12. J Clin Endocrinol Metab. 2012. PMID: 21994966 Clinical Trial.
-
BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism.Clin Endocrinol (Oxf). 2009 Nov;71(5):636-43. doi: 10.1111/j.1365-2265.2009.03528.x. Epub 2009 Jan 22. Clin Endocrinol (Oxf). 2009. PMID: 19207316
-
BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease.Clin Endocrinol (Oxf). 2012 Dec;77(6):863-70. doi: 10.1111/j.1365-2265.2012.04439.x. Clin Endocrinol (Oxf). 2012. PMID: 22587831
-
Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis.Endocrine. 2021 Oct;74(1):29-37. doi: 10.1007/s12020-021-02723-z. Epub 2021 Apr 12. Endocrine. 2021. PMID: 33846948
-
Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency.Ann Clin Biochem. 1999 Mar;36 ( Pt 2):151-7. doi: 10.1177/000456329903600203. Ann Clin Biochem. 1999. PMID: 10370729 Review.
Cited by
-
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.Front Endocrinol (Lausanne). 2022 Dec 12;13:1064024. doi: 10.3389/fendo.2022.1064024. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36578966 Free PMC article. Review.
-
Residual Corticosteroid Production in Autoimmune Addison Disease.J Clin Endocrinol Metab. 2020 Jul 1;105(7):2430-41. doi: 10.1210/clinem/dgaa256. J Clin Endocrinol Metab. 2020. PMID: 32392298 Free PMC article. Clinical Trial.
-
Interactive influence of sex, stressor timing, and the BclI glucocorticoid receptor polymorphism on stress-induced alterations of long-term memory.Brain Cogn. 2019 Jul;133:72-83. doi: 10.1016/j.bandc.2018.05.012. Epub 2018 Jun 5. Brain Cogn. 2019. PMID: 29880220 Free PMC article. Clinical Trial.
-
Two cases of infantile-onset primary generalized glucocorticoid hypersensitivity and the effect of mifepristone.BMC Pediatr. 2022 Nov 8;22(1):650. doi: 10.1186/s12887-022-03722-3. BMC Pediatr. 2022. PMID: 36348308 Free PMC article.
-
Glucocorticoid sensitivity in health and disease.Nat Rev Endocrinol. 2013 Nov;9(11):670-86. doi: 10.1038/nrendo.2013.183. Epub 2013 Oct 1. Nat Rev Endocrinol. 2013. PMID: 24080732 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical